Net Income

Toronto-based Arcadea Group acquires Adelaide's JAIX, backing the ERP provider for long-term growth and solidifying its ANZ transport tech portfolio.

With 16 top doctors and back-to-back honors, see how this practice combines elite medical care with a unique business model to lead Delaware's healthcare.

As CMS halts new provider enrollments to fight waste, one company's new model for incontinence supplies could offer a blueprint for industry-wide reform.

China's Gan & Lee partners with JW Pharmaceutical to launch its novel bi-weekly GLP-1 drug, Bofanglutide, into the competitive South Korean market.

3Play Media's new service combines AI speed with human review and deep analytics, promising to turn the guesswork of global expansion into a data-driven strategy.

A $29.7M contract for Beehive Industries' Frenzy engines signals a major U.S. military shift to an 'affordable mass' arsenal powered by 3D printing.

The EV maker is executing a massive reverse stock split to stay on Nasdaq, but tanking shares and weak financials reveal a much tougher road ahead.

New research reveals 75% of manufacturing failures happen at the factory, costing billions. The industry has been solving the wrong problem for years.

The 2026 MIECF saw a surge in deals and global participation, showcasing Macao's strategic pivot to a key player in the green economy and technology.

A new maternal blood test claims over 97% accuracy in predicting autism risk, offering hope for early intervention while igniting a fierce ethical debate.

New data reveals a surge in mental health leaves despite corporate investment, exposing a costly 'silent burnout' crisis hiding in plain sight.

U.S. Air Force awards Kraus Hamdani Aerospace a major contract for its K1000ULE drone, signaling a strategic shift in Middle East aerial warfare.

Matmut Group shatters records with a 56% profit surge, but its transformative acquisition of KOREGE signals a major strategic shift into savings and protection.

Enterprise Products Partners raises its distribution and buys back shares, showcasing financial strength ahead of key industry and earnings forecasts.

With its European trial launch, Kainova's DT-7012 aims to disarm cancer's bodyguards, offering new hope for patients with advanced solid tumors.

A new report reveals that where you live dictates your medical costs, with prices, not the care you use, driving a more than twofold spending gap.

Karl Blackburn, former head of Quebec’s top employers’ council, takes the helm at the Montreal Heart Institute Foundation, signaling a new era.

As Crocs sets its Q1 earnings call, all eyes are on the struggling HEYDUDE brand, contrasting with the core brand's strong international performance.

Eli Lilly's new once-daily oral GLP-1, Foundayo, is now on telehealth platform Ro, offering a convenient, needle-free alternative to injectable drugs.

Ease.io's annual awards highlight the leaders and technologies redefining factory excellence, from individual trailblazers to data-driven plant transformations.